5 hours Merck Enters Obesity Space, Buys Rights to Hansoh’s Oral GLP-1 Drug Zacks
Merck gets exclusive global rights to develop, manufacture and commercialize GLP-1 receptor agonist, HS-10535, from Hansoh Pharma.
Biotech · Merck&Co (MRK) · Science · Space
X